| 1 minute

US Life Sciences Company to Set Up Base in Glasgow Hospital

As part of a £10.5 million investment to life sciences, BioClavis have announced they will be creating a base in the Queen Elizabeth University Hospital in Glasgow.

A research and development grant of £4.5million has been provided by Scottish Enterprise to the firm to work in collaboration with the NHS and university researchers. BioClavis is a spin-out from molecular profiling company BioSpyder. The grant money will be used to adapt BioSpyder’s TempO-Seq platform technology into a diagnostic tool for precision medicine and will create more than 40 jobs in Glasgow.

To read the full article, click here.

Back to News

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News